| Name | Title | Contact Details |
|---|
AXIS Automation is an industry leading manufacturing company backed by over 35 years of experience and global reach. We provide a wide range of innovative automated decorating and finishing solutions for the baking and snack food industry. Our drive is our customers. Weve worked with over 400 clients, including Fortune 100 and 500 companies around the world, to perfect their product and streamline their process for greater output and less waste. We are committed to providing reliable, accurate, and efficient systems that deliver better quality product at higher production rates and lower cost. PRECISION With our machinery, consistency and quality always come first. When your product comes out just as expected, every time, you waste fewer ingredients and save more money. Our engineers work with the unique requirements of your product to achieve accurate and precise decorating and finishing solutions. FLEXIBILITY When we design our equipment, we keep in mind that giving you more possibilities allows you more control over your product. Thats why we incorporate flexibility of use into all of our machines so that you can manage which ingredients you use, application rates and production volume. INNOVATION Working with AXIS means finding the solution to your unique production requirements and achieving the consistency and accuracy your product demands. Each machine is designed with both functionality and footprint in mind to streamline your process at an economical and eco-friendly price, ensuring you the highest return on investment. The success of our customers is the result of our dedication to the precision, flexibility and innovation of our equipment that is Built to Last and Designed to Deliver.™
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Capital Bank N.A., headquartered in Rockville, Maryland is a Maryland chartered commercial bank that offers commercial and consumer banking services to clients in the Washington D.C. metropolitan area, alongside two nation-wide lending brands; Capital Bank Home Loans, a mortgage division that lends in all 50 states, and OpenSky a credit card division that offers and services credit cards across all states. Capital Bank focuses on merging digitally based products with personalized services. This enables our commercial sales teams, mortgage loan officers and OpenSky customer care associates to deliver a meaningful customer experience customized by the nature of the relationship, whether it be a credit card, a home loan, or a commercial customer with complicated lending and treasury needs. Our expansion has been deliberate with a focus on trading brick and mortar expenses for investment in digital technologies to enable our customers to focus on their goals, or their personal vision. For more information, visit https://capitalbankmd.com Member FDIC. An Equal Housing Lender. NMLS# 401599. CAPITAL BANK, PARTNERS IN YOUR VISION
Established over 100 years ago, NSK (Nippon Seiko Kabushiki Kaisha) is a Japanese-listed company that has evolved from a regional ball bearing supplier to a roller bearing specialist and automotive supplier with a global market presence. Today, NSK employs more than 31.500 employees in 29 countries. This result has been driven by ever-increasing investment in research & development, enabling the company to continuously improve the quality of its products and services. This investment supports NSKs objective of "No. 1 in Total Quality". In addition to a complete rolling bearing portfolio, NSK develops and manufactures precision components and mechatronic products, as well as systems and components for the automotive industry, including wheel bearing units and electric power-steering systems. www.nskamericas.com www.nskeurope.com www.nsk.com